Jinheng Wang

10PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyMolecular targetsInnate immunityMedical infection agents (incl. prions)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2026
Targeting the mevalonate pathway sensitizes multiple myeloma cells to bortezomib through induction of mitochondrial metabolic disruption.

|Dec 04, 2024
Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy.

Dewen Zhan, Zhimin Du, Shang Zhang

|Nov 03, 2024
Single-cell proteomics delineates murine systemic immune response to blast lung injury.

Long Li, Zhongrui Liu, Linqiang Tian

|Sep 27, 2024
GV-971 prevents severe acute pancreatitis by remodeling the microbiota-metabolic-immune axis.

Xi Chen, Xin Chen, Ding Yan

|Feb 08, 2024
Osteogenically committed hUCMSCs-derived exosomes promote the recovery of critical-sized bone defects with enhanced osteogenic properties.

Shuyi Li, Qiong Rong, Yang Zhou

|Sep 27, 2023
Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.

Hui Zhang, Zhimin Du, Chenggong Tu

Pageof 2

Frequent Collaborators

2 joint publications

Jinbao Liu

1 joint publications

Hui Zhang

1 joint publications

Zhimin Du

1 joint publications

Chenggong Tu